Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GDF2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
mRNA | MED8 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
mRNA | ZNF572 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
mRNA | POU2AF1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0008 |
mRNA | RGS16 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
mRNA | CBFA2T3 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0008 |
mRNA | GAGE12F | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
mRNA | CCDC153 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
mRNA | NDUFV1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
mRNA | COX4I2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |